Fulgent Genetics Reports Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Stay long AI-capex winners into the peak, Stifel says despite bubble fears
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Fulgent Genetics, Inc. (FLGT) Tops Q2 EPS by 5c
August 4, 2022 5:08 PM EDTFulgent Genetics, Inc. (NASDAQ: FLGT) reported Q2 EPS of $0.78, $0.05 better than the analyst estimate of $0.73. Revenue for the quarter came in at $125.3 million versus the consensus estimate of $122.7 million.
GUIDANCE:
Fulgent Genetics, Inc. sees Q3 2022 revenue of $105 million, versus the... More
